Tokyo, Jan 8, 2009 (JCN) - Daiichi Sankyo announced today that subsidiary Daiichi Pharmaceutical (Beijing) Co., Ltd. filed an application for KMD-3213 (generic name: silodosin) to China's State Food and Drug Administration (SFDA).
KMD-3213 is a selective alpha 1A-adrenoceptor antagonist developed for treatment of dysuria associated with benign prostatic hyperplasia.
Originally discovered by Kissei Pharmaceutical Co., Ltd., it was developed by Daiichi Sankyo and Kissei Pharmaceutical and is jointly marketed as Urief in Japan.
KMD-3213 has shown efficacy in significantly improving urinary disturbance soon after dosage and is expected to contribute to improving the quality of life in patients.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy
(Feb 15, 2013)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign
(Dec 20, 2012)
|
|
|
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania
(Sept 2, 2009)
|
|
|
Daiichi Sankyo Files Application for Dysuria Treatment KMD-3213 in China
(Jan 8, 2009)
|
|
|
Daiichi Sankyo and Ranbaxy Move Forward Toward The Completion of the Landmark Deal
(Oct 20, 2008)
|
|
|
Daiichi Sankyo's Tender Offer for Ranbaxy Ends in Success
(Oct 17, 2008)
|
|
|
Shionogi to Acquire U.S. Drug Maker Sciele Pharma
(Sept 1, 2008)
|
|
|
Daiichi Sankyo to Buy Indian Drug Giant Ranbaxy
(June 11, 2008)
|
|
|
Daiichi Sankyo to Acquire German Biomedical Firm
(May 21, 2008)
|
|
|
Daiichi Sankyo Launches Sales Unit in Turkey
(May 13, 2008)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
